Haga Akihiro, Nakagawa Keiichi, Shiraishi Kenshiro, Itoh Saori, Terahara Atsuro, Yamashita Hideomi, Ohtomo Kuni, Saegusa Shigeki, Imae Toshikazu, Yoda Kiyoshi, Pellegrini Roberto
Department of Radiology, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo113-8655, Japan.
Acta Oncol. 2009;48(8):1193-7. doi: 10.3109/02841860903081905.
PURPOSE. Recently, Elekta has supplied volumetric modulated arc therapy (VMAT) in which multi-leaf collimator (MLC) shape, jaw position, collimator angle, and gantry speed vary continuously during gantry rotation. A quality assurance procedure for VMAT delivery is described. METHODS AND MATERIALS. A single-arc VMAT plan with 73 control points (CPs) and 5-degree gantry angle spacing for a prostate cancer patient has been created by ERGO + + treatment planning system (TPS), where MLC shapes are given by anatomic relationship between a target and organs at risk and the monitor unit for each CP is optimized based on given dose prescriptions. Actual leaf and jaw positions, gantry angles and dose rates during prostate VMAT delivery were recorded in every 0.25 seconds, and the errors between planned and actual values were evaluated. The dose re-calculation using these recorded data has been performed and compared with the original TPS plan using the gamma index. RESULTS. Typical peak errors of gantry angles, leaf positions, and jaw positions were 3 degrees, 0.6 mm, and 1 mm, respectively. The dose distribution obtained by the TPS plan and the recalculated one agreed well under 2%-2 mm gamma index criteria. CONCLUSIONS. Quality assurance for prostate VMAT delivery has been performed with a satisfied result.
目的。最近,医科达公司提供了容积调强弧形治疗(VMAT),其中多叶准直器(MLC)形状、光阑位置、准直器角度和机架速度在机架旋转过程中连续变化。本文描述了VMAT治疗的质量保证程序。方法和材料。通过ERGO++治疗计划系统(TPS)为一名前列腺癌患者创建了一个单弧VMAT计划,该计划有73个控制点(CPs),机架角度间隔为5度,其中MLC形状由靶区与危及器官之间的解剖关系确定,每个CP的监测单位根据给定的剂量处方进行优化。在前列腺VMAT治疗过程中,每0.25秒记录一次实际的叶片和光阑位置、机架角度和剂量率,并评估计划值与实际值之间的误差。使用这些记录数据进行了剂量重新计算,并使用伽马指数与原始TPS计划进行了比较。结果。机架角度、叶片位置和光阑位置的典型峰值误差分别为3度、0.6毫米和1毫米。在2%-2毫米伽马指数标准下,TPS计划获得的剂量分布与重新计算的剂量分布吻合良好。结论。已对前列腺VMAT治疗进行了质量保证,结果令人满意。